re: Ann: Phosphagenics Further Expands Pain P... I just wish this company would give us some news. Anything.
Oh there's some...........
Does anyone get the feeling that POHs first mass production conveyor belt has just come on line?
Opiods will roll out with ease now in various formulations and delivery methods.
POH is soon to become the go to company for opiods, bar none.
They can make patches with no or little variation and can now make non systmemic topical opiod delivery. I'm sure this will be available in patches soon as well as gel.
WORLD FIRST:
Oxycodone patches
Oxymorphone patches
Topical non systemic oxycodone gel
Fentanyl topical non systemic gel or patch??
Fentanyl non abuse patches??
Oxymorphone topical non systemic gel or patch??
"Insert Opiod here" systemic patches, non systemic local patches/gels??
The production line is open and takes very little tweaking of the TPM formulation and patches to deliver a new product.
10 years of Lab work has produced an elegant solution to unmet medical needs around the world with next to no competition on the horizon in a $10+ billion dollar market.
Lets not forget the anti abuse properties that the FDA is probably? going to make manatory. Or governments may legislate for.
The deal/s when done are going to be spectacular.
Whats the old saying to make money in a gold rush? Let the miners choose the place to dig and do the digging but be the store owner that sells them the picks and shovels. POH is about to open that store. You get the drift....
And this is but one of many production lines being built. 'Mazing
- Forums
- ASX - By Stock
- AVE
- Ann: Phosphagenics Further Expands Pain Portfolio
Ann: Phosphagenics Further Expands Pain Portfolio, page-42
-
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.035K | 678.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 40284733 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39213269 | 30 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 39984733 | 0.002 |
32 | 75717741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39213269 | 30 |
0.004 | 30014232 | 16 |
0.005 | 10575266 | 9 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 13.19pm 13/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online